ABSTRACTS AND PRESENTATIONS AT MAJOR NATIONAL / INTERNATIONAL MEETINGS:
“Is Axillary Lymph Node Dissection Necessary For All T1a-b Cancer Patients? Use of Common Pathologic Findings To Predict a Negative Dissection.” D.A. Holladay, W.H. Williams, A.A. Sheikh. T. Balfour-Williams, J.B. Benton, C.T. Holladay, L.S. Maxa, S.E. Rosenbaum, P.D. Shrake, F.A. Critz. ASCO Proceedings, 22: 88, 2003.
“Practical Impact of Screening Mammography: Analysis of Pathologic Factors and Treatment Utilization For Women Undergoing Breast Conservation Therapy at a Large Radiation Therapy Center.” W.H. Williams, D.A. Holladay, A.A. Sheikh. T. Balfour-Williams, J.B. Benton, C.T. Holladay, L.S. Maxa, S.E. Rosenbaum, P.D. Shrake, F.A .Critz. ASCO Proceedings 22: 87, 2003
“Pretreatment Erectile Function Of Men Who Underwent Brachytherapy For Prostate Cancer.” F.J. Schnell, F.A. Critz, W.H. Williams, D.A. Holladay, J.B. Benton, C.T. Holladay, P.D. Shrake. ASCO Proceedings, 22: 444, 2003.
“Patient Age Related To Prostate Specific Antigen Bounce By Recursive Partitioning Analysis After Brachytherapy For Prostate Cancer.” F.A. Critz, W.H. Williams, D. Holladay, J.B. Benton, F.J. Schnell, C.T. Holladay, P.D. Shrake, A Ciampi, A. Couturier. ASCO Proceedings, 22: 438, 2003.
“Patient Age Is Related To Prostate Specific Antigen Bounce After Brachytherapy For Prostate Cancer.”F.A. Critz, W.H. Williams, A.K. Levinson, J.B. Benton, F.J. Schnell, C.T. Holladay, P.D. Shrake. ABS Proceedings, 67, 2003.
“Cigarette Smoking Does Not Affect Treatment Results of Simultaneous Irradiation For Prostate Cancer.:” J.B. Benton, F.A. Critz,, W.H. Williams, A.K. Levinson, F.J. Schnell, C.T. Holladay, P.D. Shrake. ASCO Proceedings, 22: 444, 2003.
“Ten Year Disease Free Survival Rate According To Age In Men After Brachytherapy For Prostate Cancer.”: J.B. Benton, F.A. Critz, W.H. Williams, C.T. Holladay, and P.D. Shrake. AUA Meeting, San Francisco, 2004.
“Postirradiation Prostatitis: A Previously Unrecognized Syndrome Following Brachytherapy For Prostate Cancer.” F.A. Critz, A. K. Levinson, W.H. Williams, J.B. Benton, F.J. Schnell, C.T. Holladay, P.D. Shrake. ABS Proceedings, 66, 2003.
“Obstructive Uropathy Following Simultaneous Irradiation For Prostate Cancer Measured By A Longitudinal Study Of The American Urological Association Symptom Index For Benign Prostate Hyperplasia.”F.A. Critz, W.H. Williams, A. Keith Levinson, James B. Benton, F.J. Schnell, C.T. Holladay, Philip D. Shrake. ABS Proceedings, 67, 2003.
“Ten-Year Disease Free Survival Rate Calculated With PSA Cutpoint 0.2 ng/ml In Men After Brachytherapy For Prostate Cancer.”F.A. Critz, W.H. Williams, A. Keith Levinson, James B. Benton, F.J. Schnell, Clinton T. Holladay, Philip D. Shrake. AUA Meeting, Chicago, IL, 2003.
“Prostate Specific Antigen Nadir After Brachytherapy For Prostate Cancer Correlates With Prognosis Of Men Who Recur.”F.A. Critz, A. Keith Levinson, W.H. Williams, James B. Benton, F.J. Schnell, Clinton T. Holladay, Philip D. Shrake. AUA Meeting, Chicago, IL 2003.
“African-American Race Does Not Impact Local Recurrence Risk Following Conservation Therapy for Breast Cancer”. W.H. Williams, D.A. Holladay, A.A. Sheikh, C.T. Holladay, F.A. Critz, P. Shrake, L. Maxa, J. Gargus, J. Benton, R. Tarlton, F. Schnell, S. Rosenbaum, S. Edelman. ASTRO Proceedings, 54, 2002.
“Disease Free Survival Rates Following Irradiation of Prostate Cancer According to Age”. J.B. Benton, F.A. Critz, H. Williams, F.J. Schnell, C.T. Holladay, P.D. Shrake. ASCO Proceedings, 21, 2002.
“Young Age Independently Predicts Local Failure For Women Undergoing Breast Conservation in the Community Setting”. W.H. Williams, D.A. Holladay, A.A. Sheikh, C.T. Holladay, F.A. Critz, P. Shrake, L. Maxa, J. Gargus, R. Tarlton, J.B. Benton, S. Rosenbaum, S. Edelman, F. Schnell. ASCO Proceedings, 21, 2002.
“Sexual Function Following Simultaneous Irradiation for Prostate Cancer”. F.A. Critz, J.B. Benton, H. Williams, F.J. Schnell, P.D. Shrake, C.T. Holladay. ASCO Proceedings, 21, 2002.
“African-American Race Does Not Predict a Higher Risk of Local Recurrence Following Breast Conservation Therapy in the Community Setting”. D.A. Holladay, W.H. Williams, A.A. Sheikh, P. Shrake, F.A. Critz, C. Holladay, S. Rosenbaum, R. Tarlton, J.B. Benton, F. Schnell, L. Maxa, J. Gargus, S. Edelman. ASCO Proceedings, 21, 2002.
“Results of Simultaneous Irradiation at Radiotherapy Clinics of Georgia ”. H. Williams, Ocala Regional Cancer Center Prostate Cancer Seminar, May, 2001, Orlando , Florida .
“A Standard Definition of Disease Freedom is Needed for Prostate Cancer”. F Critz, H Williams, J Benton, C Holladay, F Schnell, P Shrake. American Brachytherapy Society Meeting. ABS Proceedings 57, 2001.
“Acute and Late Morbidity Following Simultaneous Irradiation for Prostate Cancer.” F.A. Critz, H. Williams, K. Levinson, C. Holladay, F.Schnell, J.Benton, P.Shrake. ASCO Proceedings 20, 2001.
“Breast Conservation in the Community Setting for Invasive Ductal Carcinoma,” W.H. Williams, D.A. Holladay, F.A.Critz, A. Sheikh, European Conference on Cancer Strategies and Outcomes, March, 2001, Edinburgh, Scotland
“Community-Based Breast Conservation for Ductal Carcinoma in Situ Using Lumpectomy and Radiation Therapy.” Holladay, J.B. Benton, F. Schnell, P. Shrake, L. Maxa, R. Tarlton, S. Rosenbaum. ASCO Proceedings 20, 2001.
“Outcome of Breast Conservation for Invasive Carcinoma in the Community Setting: a Retrospective Review.” D.Holladay, H. Williams, F.A. Critz, A. Sheikh, R. Tarlton, S. Rosenbaum, J. Benton, C. Holladay, P.Shrake, J. Gargus, L. Maxa. ASCO Proceedings 20, 2001.
“Urinary Obstruction Following Brachytherapy Treatment of Prostate Cancer”. F.A. Critz, W.H. Williams, A.A. Sheikh, C.T. Holladay, D.A. Holladay, P.D. Shrake, A.D. Levinson, J.B. Benton. ASCO Proceedings 19, 2000.
“T1C Adenocarcinama of the Prostate Treated by Simultaneous Irradiation: Patient Characteristics and Clinical Results”. W.H. Williams, III, F.A. Critz, J.B. Benton, D.A. Holladay, C.T. Holladay, P.D. Shrake, F.J. Schnell, A.K. Levison. ASCO Proceedings 19, 2000.
“Analysis of Sporadic versus Familial Prostate Cancer for Men Treated with Simultaneous Irradiation”. C.T. Holladay, F.A. Critz, W.H. Williams, A.K. Levinson, A.A. Sheikh, F. Schnell, P. Shrake, D.A. Holladay. ASCO Proceedings 19, 2000.
“Bilateral Prostate Cancer Does NOT Impact Outcome of Men Treated with Simultaneous Irradiation”. J.B. Benton, W.H. Williams, F.A. Critz, A.K. Levinson, A.A. Sheikh, C.T. Holladay, D.A. Holladay, F.J. Schnell, P.D. Shrake. ASCO Proceedings 19, 2000.
“Young Men with Prostate Cancer Treated by Simultaneous Radiotherapy”. A.A. Sheikh, F.A. Critz, W. Williams, A.K. Levinson, J.B. Benton, C.T. Holladay, F. Schnell, P. Shrake, D.A. Holladay, L.S. Maxa. ASCO Proceedings 19, 2000.
“The Normal Prostate Specific Antigen Response in Men Disease-Free of Prostate Cancer After Simultaneous Radiation.” F.A. Critz, W.H. Williams, A. K. Levinson, C. T. Holladay, J.B. Benton, F.J. Schnell, P.D. Shrake. J Urol 163: 4, 2000.
"PSA Bounce Following Radioactive Seed Implantation for Prostate Cancer.” F.A. Critz, H. Williams, A.K. Levinson, C.T.Holladay, V. Griffin, J. Benton, D.A. Holladay. J. Urol. 161: 4, 1999, J Brachytherapy Int.,15, 1999.
“Treatment of Gleason Score 7 Prostate Cancer with I-125 Implant Followed by External Beam Radiotherapy.” J.Benton, F.A. Critz, H.Williams,K.Levinson,C. Holladay, V. Griffin, D. Holladay . ASCO Proceedings 18, 1999.
“Prostate Cancer in African-American Men Treated by Simultaneous Radiotherapy.” F.Critz, H. Williams, K. Levinson, C. Holladay, V. Griffin, J. Benton, D. Holladay. ASCO Proceedings 18, 1999.
“Probability of Achieving PSA Nadir £ 0.5 Ng/ml After Radiotherapy of Prostate Cancer.” V.Griffin, F. Critz, H. Williams, K. Levinson, C. Holladay, J. Benton, D. Holladay. ASCO Proceedings 18, 1999.
“Use of A Genetically Engineered Neural Network (GENN) to Predict Achievement of PSA Nadir £ 0.5 ng/ml in Men Treated with Simultaneous Irradiation (SRT) for Prostate Cancer (PCA). C. Holladay, F. Critz, W.H. Williams, M. Craig Miller, A.K.Levinson, R.W. Veltri. ASCO Proceedings 18, 1999.
“Recursive Partitioning Analysis of PSA Nadir to Predict Disease Freedom in Prostate Cancer Patients with Minimum 5 Year Followup.” H.Williams, F.Critz, K. Levinson, C. Holladay, V. Griffin, J. Benton, D. Holladay, A. Ciampi, A. Couturier. ASCO Proceedings 18, 1999.
“An Evaluation of the ASTRO Committee Definition of Disease Freedom after Radiotherapy of Prostate Cancer”. W.H. Williams, F.A. Critz, A.K. Levinson, D.A. Holladay, C.T. Holladay, V.D. Griffin. ASCO Proceedings. 17: 313 A, 1998.
“African-American Men Treated by I-125 Prostate Implant Followed External Beam Radiation for Prostate Cancer”. F.A. Critz, A.K. Levinson, W.H. Williams, D.A. Holladay, C.T. Holladay, V.D. Griffin. ASCO Proceedings 17: 329 A. 1998
“I-125 Prostate Implant Followed by External-Beam Radiation for Prostate Cancer”. V.D. Griffin, F.A. Critz, A.K. Levinson, W.H. Williams, D.A. Holladay, C.T. Holladay. ASCO Proceedings 17: 332 A., 1998.
“Young Men With Prostate Cancer Treated by Simultaneous Radiotherapy”. C.T. Holladay, F.A. Critz, A.K. Levinson, W.H. Williams, D.A. Holladay, V.D. Griffin. ASCO Proceedings 17: 334 A. 1998.
“Continuous Prospective Self-Administered Patient Questionnaires To Determine Morbidity After Simultaneous Radiation of Prostate Cancer”. D.A. Holladay, F.A. Critz, W.H. Williams, A.K. Levinson, V.D. Griffin, C.T. Holladay. ASCO Proceedings 17: 334 A, 1998.
“Young Men With Prostate Cancer Treated by Simultaneous Radiotherapy”. F.A. Critz, E.Harrison, W.Falconer, V.D. Griffin, W.H. Williams, D.A. Holladay, C.T. Holladay. National Medical Association Meeting, New Orleans , 1998.
“Simultaneous Radiation of Prostate Cancer: I-125 Prostate Implant Followed by External-Beam Radiation for Prostate Cancer”. V.D. Griffin, F.A. Critz, E. Harrison, W. Falconer, W.H. Williams, D.A. Holladay, C.T. Holladay. National Medical Association Meeting, New Orleans , 1998.
“African-American Men Treated by I-125 Prostate Implant Followed by External-Beam Radiation For Clinical Stage T1T2N0 Prostate Cancer”. F.A. Critz, E. Harrison, W. Falconer, V.D. Griffin, W.H. Williams, D.A. Holladay, C.T. Holladay. National Medical Association Meeting, New Orleans , 1998.
“Prostate Cancer Treated by Simultaneous Radiotherapy: I-125 Prostate Implant Followed by External-Beam Radiation”. A.K. Levinson, F.A. Critz, W.H. Williams, D.A. Holladay, C. T. Holladay, Vivian D. Griffin. J of Urol 159: 63, 1998.
“The PSA Nadir Goal for Radiotherapy of Prostate Cancer is £ 0.2 ng/ml”. F.A. Critz, A.K. Levinson, W.H. Williams, D.A. Holladay, C.T. Holladay, V.D. Griffin. J of Urol 159:218, 1998.
“Radiation Prostatectomy: A New Treatment Concept For Prostate Cancer”. F.A. Critz, A.K. Levinson, W.H. Williams, D.A. Holladay, C.T. Holladay, V.D. Griffin. ASCO Proceedings, May 1997.
“PSA Nadir £ 0.5 ng/ml Defines Disease-Freedom After Radiotherapy Of Prostate Cancer.”F. A. Critz, , A. K. Levinson, , W. H. Williams, et al, American Radium Society, New York City, New York, May 1997.
“ A Precise Definition of Disease Free Survival Following Irradiation For Prostate Cancer.” F. A. Critz, A. K Levinson, W. H. Williams, D. A. Holladay, et al, American Urologic Association, New Orleans LA, April 1997.
“Combination Implant Followed by External Beam Radiation For Prostate Cancer: Outcome Defined With PSA Nadir £ 0.5 ng/ml.” F A Critz, , W.H. Williams, , A.K. Levinson, , C. T. Holladay, V. D. Griffin, , and D. A. Holladay, Seventh International Congress on Anti-Cancer Treatment, Paris, France, February, 1997.
“10 Year PSA Monitored Follow-up in Surgically Staged Prostate Cancer Patients Treated with Irradiation” F.A. Critz, W.H. Williams, A.K. Levinson, D.A. Holladay, C.T.Holladay, American Society for Therapeutic Radiology and Oncology, Los Angeles, CA, October 1996
“What PSA Nadir Should be Achieved After Irradiation for Prostate Cancer?” F.A. Critz, A.K. Levinson, W.H. Williams, and D.A. Holladay, American Radium Society, San Francisco, CA, April, 1996
“The PSA Nadir Level Needed After Radiation for Prostate Cancer”. FA Critz, A.K. Levinson, W.H. Williams, D.A. Holladay. American Radium Society Meeting, San Francisco, CA., April 1996.
“The PSA Nadir After Radiation For Prostate Cancer”. F.A. Critz, A..K. Levinson, D.A. Holladay, W.H. Williams. Amer Urol Assoc Meeting, Orlando, Florida. J of Urol. 155: 984, 1996.
“The Optimal PSA Nadir After Irradiation for Prostate Cancer” F.A. Critz, A.K. Levinson, W.H. Williams, and D.A. Holladay, Sixth International Congress on Anti-Cancer Treatment, Paris, France, February, 1996
“PSA-Monitored 10 Year Data of Combination I-125 Implant Followed by External-Beam Radiation for Prostate Cancer” F.A. Critz, R.S. Tarlton, D.A. Holladay and W.H. Williams, American Society of Clinical Oncology, Los Angeles, CA, May 1995
"Brachytherapy of Primary and Recurrent Gliomas: Impact of Age and Performance Status on Results of Therapy" W.H. Williams, J.J. Olson, I.R. Crocker, J. C. Landry, L. W. Davis, J. Billingsley, Am Radium Soc, Paris, FR, 1995
“Comparative Value of I-125 Brachytherapy in the Treatment of Progressive Malignant Gliomas" J.J. Olson, H. Williams, I. Crocker, J. Billingsley, American Association of Neurological Surgery, Orlando, FL, 1995
“Prostate Cancer: Long Term PSA-Monitored Results of Treatment With I-125 Implant Plus External-Beam Radiation”. F.A. Critz, R.S. Tarlton, D.A. Holladay, Amer Soc of Clin Oncol.,Dallas, TX, May, 1994. ASCO Proceedings 13: A 700, 1994.
“Prostate Cancer: Comparison of Tranasperineal vs Retropubic Implant Techniques With PSA Monitoring”. F.A. Critz, R.S. Tarlton, D.A. Holladay, American Radium Society Bermuda, April 1994.
"Definitive Radiation Therapy for Extrahepatic Bile Duct Carcinoma” K. Tsujino, J.C. Landry, R.G. Smith, W.H. Williams, L.W. Davis, Rad Society of North America, Chicago, IL, 1994
"Intraoperative Brachytherapy: Rationale and Future Directions" D. Nori and H. Williams, 7th International Brachytherapy Working Conference, Baltimore/Washington, D.C., 1992
"Influence of Fraction Size on Repair Kinetics in V-79 Cells" Reddy, N.M.S., Williams, H., Reiner, S., Mayer, P.J., Lange, C.S., Radiation Research Society Annual Meeting, Salt Lake City, Utah, 1992
"Multiple Cholinergic Receptors on Vestibular Hair Cells" Norris, C.H., Guth, P.S. and Williams, H., Association for Research in Otolaryngology, 1986
Effect of Carbachol on Evoked Neural Population Responses in the Isolated Semicircular Canal" Guth, S.L., Norris, C.H. and Williams, H., Association for Research in Otolaryngology, 1985
"The Acetylcholine Receptors of the Semicircular Canal" Guth, P.S., Norris, C.H. and Williams, H., Society for Neuroscience, Dallas, Texas, 1985
“Prostate Specific Antigen Bounce After Simultaneous Irradiation For Prostate Cancer: The Relationship To Patient Age.” F.A. Critz, W.H. Williams, A.K. Levinson, James B. Benton, F.J. Schnell, C.T. Holladay, P.D. Shrake. J. Urol 170:1864-1867, November 2003.
“Results of Interstitial Brachytherapy for Malignant Brain Tumors”. M.T. Mayr, I.R. Crocker, E.K. Butker, W.H. Williams, G.A. Cotsonis, J.J. Olson. Int J Oncol. 2002 Oct;21(4):817-23.
“Simultaneous Irradiation for Prostate Cancer: Intermediate Results with Modern Techniques”. F.A. Critz, W.H. Williams, A.K. Levinson, J.B. Benton, C.T. Holladay, F.J. Schnell J.Urol.,164, 3, Sept.2000)
“Prostate Specific Antigen Bounce After Radioactive Seed Implantation Followed by External Beam Radiation For Prostate Cancer.” F.A. Critz, W.H. Williams, J.B. Benton, A.K. Levinson, C.T. Holladay, D.A. Holladay. J. Urol. 163: 1085-1089, 2000.
“African-American Men with Prostate Cancer Treated by Simultaneous Irradiation”. W.H. Williams, F.A. Critz, J.B. Benton, K. Levinson, W. Falconer, E. Harrison, C.T.Holladay, D.A. Holladay.” The Prostate Journal 2: 80-87, 2000.
“Post-Treatment PSA £ 0.2 ng/ml Defines Disease Freedom After Radiotherapy For Prostate Cancer Using Modern Techniques.” F.A. Critz, W.H.Williams, Clinton Holladay , A.K. Levinson, James Benton et. al. Urol. 54: 968-971, 1999.
“Prostate Specific Antigen Nadir Achieved by Men Apparently Cured of Prostate Cancer by Radiotherapy”. F.A.Critz, A.K. Levinson, W.H. Williams, Clinton T. Holladay, Vivian D. Griffin, David A. Holladay. J. Urol. 161: 1199-1205, 1999.
“ Simultaneous Radiotherapy For Prostate Cancer: I-125 Prostate Implant Followed by External Beam Radiation.” F.A. Critz, A.K. Levinson, W.H. Williams, C.T. Holladay et al. The CA Journal from Sci Amer. 4: 359-363, 1998.
“PSA Nadir <0.5 ng/ml Defines Disease Freedom for Surgically Staged Men Irradiated for Prostate Cancer” F.A. Critz, A.K. Levinson, W.H. Williams, D.A. Holladay, C.T. Holladay, V. Griffin , Rapid Communication, Urology, May, 1997
“The PSA Nadir That Indicates Potential Cure After Radiotherapy for Prostate Cancer”F.C. Critz, A.K. Levinson, W.H. Williams, D.A. Holladay, C.T. Holladay,, Rapid Comm., Urology, March, 1997
“Prostate-Specific Antigen Nadir: The Optimum Level After Irradiation for Prostate Cancer”F.A. Critz, A.K. Levinson, W.H. Williams, and D.A. Holladay, Journal of Clinical Oncology, Vol 14, No 11 (November) 1996: 2893-2900
"Definitive Radiation Therapy for Extrahepatic Bile Duct Carcinoma" K. Tsujino, J.C. Landry, R.G. Smith, W.H. Williams, L.W. Davis, Radiology, 1995; 196: 275-280
“Hemodynamic Predictors of Outcome in Patients Undergoing Valve Replacement"Carabello, B.A., Williams, H., Gash, A., Kent, R., Belber, D., Maurer, A., Siegel, J., Blasius, K., and Spann, J., Circulation, December, 1986; 74 (6): 1309-1316
"Cholinomimetics Mimic Efferent Effect of Semicircular Canal Afferent Activity in the Frog" Guth, P.S., Norris, C.H., Guth, S.L., Quine, D.B., Williams, W.H., Acta Otolaryngologica ( Stockholm ) 1986; 102: 194-203
"The Acetylcholine Receptors of the Frog (Rana pipiens) Semicircular Canal" Housley, G.H., Norris, C.H., Williams, W.H., and Guth, P.S., Hearing Research, Feb-Mar, 1985 32 (3): 197-206
Please call Radiation Oncology of Atlanta at 404-705-9192, or contact us here if you have questions or want to schedule a consultation or follow-up appointment.